By Admin at 4 Jan 2016
Researchers have found a less invasive, more affordable option to monitor cancer development and its response to treatment in real time dubbed “liquid biopsy,” which could change the future of cancer care.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
